Comparable performance of 1,5-anhydroglucitol and continuous glucose monitoring in detecting subclinical atherosclerosis in elderly patients with type 2 diabetes
In older adults with type 2 diabetes, 1,5-AG demonstrated a performance comparable to CGM for detecting abnormal CIMT, supporting its potential as a clinical biomarker for identifying subclinical atherosclerosis.
Authors
- Jian Zhou (ORCID: https://orcid.org/0000-0002-1534-2279)
- Jingyi Lu (ORCID: https://orcid.org/0000-0003-1105-4189)
- Xiaojing Ma (ORCID: https://orcid.org/0000-0003-3043-1840)
- Hang Su (ORCID: https://orcid.org/0000-0001-6970-4792)
- Yufei Wang (ORCID: https://orcid.org/0000-0002-0781-5013)
- Wei Zhu (ORCID: https://orcid.org/0000-0003-2312-1174)
- Danfeng Peng (ORCID: https://orcid.org/0000-0003-0014-8817)
- Wei Lu
- Jiaying Ni
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Sixth People's Hospital (CN)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1186/s12933-025-02993-1
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science and Technology Major Project
- Sanming Project of Medicine in Shenzhen